Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion type Assertion NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_head.
- NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion description "[The MET/ALK/ROS1 inhibitor crizotinib (Xalkori, PF-02341066) has demonstrated promising clinical activity in ROS1 fusion-positive non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_provenance.
- NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion evidence source_evidence_literature NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_provenance.
- NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion SIO_000772 25733882 NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_provenance.
- NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion wasDerivedFrom befree-2016 NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_provenance.
- NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_assertion wasGeneratedBy ECO_0000203 NP1267676.RASkSbv9872uedZhitj0GtSDRJGgSxzJ4tKEPPXGogpL4130_provenance.